Cover Image
市場調查報告書

喘鳴:全球臨床實驗檢討

Wheezing Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 322172
出版日期 內容資訊 英文 69 Pages
訂單完成後即時交付
價格
Back to Top
喘鳴:全球臨床實驗檢討 Wheezing Global Clinical Trials Review, H2, 2014
出版日期: 2014年12月31日 內容資訊: 英文 69 Pages
簡介

本報告提供喘鳴的臨床實驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床實驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 喘鳴
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

G7各國臨床實驗數量:呼吸系統疾病臨床實驗上喘鳴所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:呼吸系統疾病臨床實驗上喘鳴所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

喘鳴治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • AstraZeneca PLC
    • Merck & Co., Inc.
    • GlaxoSmithKline plc
    • Amphastar Pharmaceuticals, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Milton S. Hershey Medical Center
    • National Hospital Organization Mie National Hospital
    • University of Massachusetts
    • Albert Einstein College of Medicine of Yeshiva University
    • Case Western Reserve University
    • UMC Utrecht Holding BV
    • Oregon Health & Science University
    • Chinese University of Hong Kong
    • Queen's University
    • University of Calgary

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2519CTIDB

GlobalData's clinical trial report, "Wheezing Global Clinical Trials Review, H2, 2014" provides data on the Wheezing clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Wheezing. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Wheezing. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Wheezing
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of wheezing to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of wheezing to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Wheezing
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in wheezing Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Amphastar Pharmaceuticals, Inc.
      • Clinical Trial Overview of Amphastar Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Milton S. Hershey Medical Center
      • Clinical Trial Overview of Milton S. Hershey Medical Center
      • National Hospital Organization Mie National Hospital
      • Clinical Trial Overview of National Hospital Organization Mie National Hospital
      • University of Massachusetts
      • Clinical Trial Overview of University of Massachusetts
      • Albert Einstein College of Medicine of Yeshiva University
      • Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University
      • Case Western Reserve University
      • Clinical Trial Overview of Case Western Reserve University
      • UMC Utrecht Holding BV
      • Clinical Trial Overview of UMC Utrecht Holding BV
      • Oregon Health & Science University
      • Clinical Trial Overview of Oregon Health & Science University
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • Queen's University
      • Clinical Trial Overview of Queen's University
      • University of Calgary
      • Clinical Trial Overview of University of Calgary
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Wheezing Therapeutics, Global, Clinical Trials by Region, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Wheezing Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Wheezing Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Wheezing Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Wheezing Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Wheezing Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Wheezing to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Wheezing Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Wheezing Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Wheezing to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Wheezing Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Wheezing Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Wheezing Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Wheezing Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Wheezing Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Wheezing Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Amphastar Pharmaceuticals, Inc., 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Milton S. Hershey Medical Center, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by National Hospital Organization Mie National Hospital, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Western Reserve University, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2014*

List of Figures

  • Wheezing Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Wheezing Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Wheezing Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Wheezing Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Wheezing Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Wheezing Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Wheezing to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Wheezing Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Wheezing Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Wheezing to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Wheezing Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Wheezing Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Wheezing Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Wheezing Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top